Publikationen von M. Zweckstetter

Liu, H.; Koros, C.; Strohäker, T.; Schulte, C.; Bozi, M.; Varvaresos, S.; de Opakua, A. I.; Simitsi, A. M.; Bougea, A.; Voumvourakis, K. et al.; Maniati, M.; Papageorgiou, S. G.; Hauser, A.‐.; Becker, S.; Zweckstetter, M.; Stefanis, L.; Gasser, T.: A novel SNCA A30G mutation causes familial Parkinsonʼs disease. Movement Disorders, In Press (2021)

Gray, A. L. H.; Steren, C. A.; Haynes, I. W.; Bermejo, G. A.; Favretto, F.; Zweckstetter, M.; Do, T. D.: Structural Flexibility of Cyclosporine A Is Mediated by Amide Cis–Trans Isomerization and the Chameleonic Roles of Calcium. Journal of Physical Chemistry B 125 (5), S. 1378 - 1391 (2021)

Sieger, A.; Rankovic, M.; Favretto, F.; Ukmar‐Godec, T.; Strohäker, T.; Becker, S.; Zweckstetter, M.: Interplay between tau and α‐synuclein liquid–liquid phase separation. Protein Science, In Press (2021)

Savastano, A.; Flores, D.; Kadavath, H.; Biernat, J.; Mandelkow, E.; Zweckstetter, M.: Disease‐associated tau phosphorylation hinders tubulin assembly within tau condensates. Angewandte Chemie International Edition 60 (2), S. 726 - 730 (2021)

Savastano, A.; Jaipuria, G.; Andreas, L. B.; Mandelkow, E.; Zweckstetter, M.: Solid-state NMR investigation of the involvement of the P2 region in tau amyloid fibrils. Scientific Reports 10, 21210 (2020)

Lott, A.; Oroz, J.; Zweckstetter, M.: Molecular basis of the interaction of Hsp90 with its co‐chaperone Hop. Protein Science 29 (12), S. 2422 - 2432 (2020)

Favretto, F.; Flores, D.; Baker, J. D.; Strohäker, T.; Andreas, L. B.; Blair, L. J.; Becker, S.; Zweckstetter, M.: Catalysis of proline isomerization and molecular chaperone activity in a tug-of-war. Nature Communications 11, 6046 (2020)

Savastano, A.; Ibanez de Opakua, A.; Rankovic, M.; Zweckstetter, M.: Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. Nature Communications 11, 6041 (2020)

Dominguez-Meijide, A.; Vasili, E.; König, A.; Cima-Omori, M.-S.; Ibáñez de Opakua, A.; Leonov, A.; Ryazanov, S.; Zweckstetter, M.; Griesinger, C.; Outeiro, T. F.: Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization. Scientific Reports 10, 12827 (2020)

Ukmar-Godec, T.; Fang, P.; Ibáñez de Opakua, A.; Henneberg, F.; Godec, A.; Pan, K. T.; Cima-Omori, M.-S.; Chari, A.; Mandelkow, E.; Urlaub, H. et al.; Zweckstetter, M.: Proteasomal degradation of the intrinsically disordered protein tau at single-residue resolution. Science Advances 6 (30), eaba3916 (2020)

Gerdes, C.; Waal, N.; Offner, T.; Fornasiero, E. F.; Wender, N.; Verbarg, H.; Manzini, I.; Trenkwalder, C.; Mollenhauer, B.; Strohäker, T. et al.; Zweckstetter, M.; Becker, S.; Rizzoli, S. O.; Basmanav, F. B.; Opazo, F.: A nanobody-based fluorescent reporter reveals human α-synuclein in the cell cytosol. Nature Communications 11, 2729 (2020)

de Opakua, A. I.; Klama, F.; Ndukwe, I. E.; Martin, G. E.; Williamson, T. R.; Zweckstetter, M.: Determination of complex small molecule structures using molecular alignment simulation. Angewandte Chemie International Edition 59 (15), S. 6172 - 6176 (2020)

Favretto, F.; Baker, J.; Strohäker, T.; Andreas, L.; Blair, L.; Becker, S.; Zweckstetter, M.: Molecular basis of the interaction of cyclophilin A with alpha-synuclein. Angewandte Chemie International Edition 132 (14), S. 5692 - 5695 (2020)

Ukmar-Godec, T.; Wegmann, S.; Zweckstetter, M.: Biomolecular condensation of the microtubule-associated protein tau. Seminars in Cell and Developmental Biology 99, S. 202 - 214 (2020)

Hamann, F.; Schmitt, A.; Favretto, F.; Hofele, R.; Neumann, P.; Xiang, S. Q.; Urlaub, H.; Zweckstetter, M.; Ficner, R.: Structural analysis of the intrinsically disordered splicing factor Spp2 and its binding to the DEAH-box ATPase Prp2. Proceedings of the National Academy of Sciences of the United States of America 117 (6), S. 2948 - 2956 (2020)

Masaracchia, C.; König, A.; Valiente-Gabioud, A. A.; Peralta, P.; Favretto, F.; Strohäker, T.; Lázaro, D. F.; Zweckstetter, M.; Fernandez, C. O.; Outeiro, T. F.: Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica et Biophysica Acta-Proteins and Proteomics 1868 (1), 140298 (2020)

Strohäker, T.; Jung, B. C.; Liou, S. H.; Fernandez, C. O.; Riedel, D.; Becker, S.; Halliday, G. M.; Bennati, M.; Kim, W. S.; Lee, S. J. et al.; Zweckstetter, M.: Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts. Nature Communications 10, 5535 (2019)

Pellkofer, H.; Ihler, F.; Weiss, B. G.; Trothe, J.; Kadavath, H.; Chongtham, M.; Kunadt, M.; Riedel, D.; Lornsen, F.; Wilken, P. et al.; Bartels, C.; Hirschel, S.; Russo, S. G.; Stransky, E.; Trojan, L.; Schmidt, B.; Mandelkow, E.; Zweckstetter, M.; Canis, M.; Schneider, A.: Evaluation of the methoxy-X04 derivative BSC4090 for diagnosis of prodromal and early Alzheimer's disease from bioptic olfactory mucosa. European Archives of Psychiatry and Clinical Neuroscience 269 (8), S. 973 - 984 (2019)

Zhang, D.; Bedogni, F.; Boterberg, S.; Camfield, C.; Camfield, P.; Charman, T.; Curfs, L.; Einspieler, C.; Esposito, G.; De Filippis, B. et al.; Goin-Kochel, R. P.; Höglinger, G. U.; Holzinger, D.; Iosif, A. M.; Lancioni, G. E.; Landsberger, N.; Laviola, G.; Marco, E. M.; Müller, M.; Neul, J. L.; Nielsen-Saines, K.; Nordahl-Hansen, A.; O'Reilly, M. F.; Ozonoff, S.; Poustka, L.; Roeyers, h.; Rankovic, M.; Sigafoos, J.; Tammimies, K.; Townend, G. S.; Zwaigenbaum, L.; Zweckstetter, M.; Bölte, S.; Marschik, P. B.: Towards a consensus on developmental regression. Neuroscience and Biobehavioral Reviews 107, S. 3 - 5 (2019)

Mavroeidi, P.; Arvanitaki, F.; Karakitsou, A. K.; Vetsi, M.; Kloukina, I.; Zweckstetter, M.; Giller, K.; Becker, S.; Sorrentino, Z. A.; Giasson, B. I. et al.; Jensen, P. H.; Stefanis, L.; Xilouri, M.: Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models. Acta Neuropathologica 138 (3), S. 415 - 441 (2019)